By: Linda Watts
Eli Lilly, Novo Nordisk and the FDA met in June of last year to discuss how to make insulin bottles more distinguishable for the visually impaired. Participants agreed that a coding system using horizontal raised bars would be the most effective. If the FDA accepts the plan, the four code categories will be as follows: one bar for rapid-acting insulin analogs, two bars for regular insulins, three bars for insulin mixtures and four bars for intermediate- and long-acting insulins.
“The new coding system should only raise the price of the bottles by a few cents,” says Ed Bryant, editor of Voice of the Diabetic and participant in June’s meeting. “FDA approval of the system is expected,” adds Bryant.